P.R. Herzig & Co’s GSK GSK Stock Holding History

P.R. Herzig & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-17,526	Closed	-$883K	–	18
2018 Q2	$883K	Sell	17,526 -3,474	-17%	-$175K	1.92%	24
2018 Q1	$1.03M	Buy	21,000 +240	+1%	+$11.2K	2.06%	21
2017 Q4	$920K	Sell	20,760 -9,360	-31%	-$432K	1.77%	22
2017 Q3	$1.53M	Hold	30,120	–	–	2.96%	15
2017 Q2	$1.62M	Hold	30,120	–	–	3.14%	14
2017 Q1	$1.59M	Sell	30,120 -240	-0.8%	-$12.2K	3.08%	15
2016 Q4	$1.46M	Sell	30,360 -1,440	-5%	-$71.1K	2.98%	12
2016 Q3	$1.71M	Buy	31,800 +560	+2%	+$30.7K	3.36%	10
2016 Q2	$1.69M	Buy	31,240 +1,680	+6%	+$88.5K	3.57%	9
2016 Q1	$1.5M	Buy	29,560 +3,760	+15%	+$187K	3.28%	7
2015 Q4	$1.3M	Buy	25,800 +1,600	+7%	+$81.6K	3.14%	9
2015 Q3	$1.16M	Buy	24,200 +2,000	+9%	+$104K	2.92%	13
2015 Q2	$1.16M	Buy	+22,200	New	+$1.25M	2.34%	16

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

P.R. Herzig & Co's GSK Position: Q3 2018 in Review

P.R. Herzig & Co sold out of GSK (GSK) in Q3 2018, closing a stake of 17,526 shares — an estimated $883K sold.

P.R. Herzig & Co first reported a position in GSK in Q2 2015 and held it in 13 quarters. The position peaked at $1.71M in Q3 2016. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

P.R. Herzig & Co reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
P.R. Herzig & Co sold 17,526 GSK shares in Q3 2018, an estimated $883K.
P.R. Herzig & Co first reported a position in GSK in Q2 2015 and held it in 13 quarters.
P.R. Herzig & Co's GSK position peaked at $1.71M in Q3 2016.
787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on P.R. Herzig & Co's 13F filing for Q3 2018.